Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 7, 2015; 21(5): 1457-1467
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1457
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1457
Figure 1 Immunohistochemical study findings of colorectal cancers (magnification × 200).
A: CK7 expression; B: Retained CK20 expression; C: Retained CDX2 expression; D: CK7 no-expression; E: Decreased CK20 expression; F: Loss of CDX2 expression. CK: Cytokeratin.
- Citation: Bae JM, Lee TH, Cho NY, Kim TY, Kang GH. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. World J Gastroenterol 2015; 21(5): 1457-1467
- URL: https://www.wjgnet.com/1007-9327/full/v21/i5/1457.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i5.1457